Tazarotene Cream
Product Images NDC 72162-2420

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tazarotene (NDC 72162-2420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Extended Label (721622420extendedlabel)

The text provides information on the dosage instructions for Tazarotene Cream, 0.05% when treating psoriatic lesions. It advises applying the cream once per day in the evening, using a thin film to cover only the lesion. It also mentions the importance of ensuring the skin is dry before application and that emollients should be applied at least an hour before the cream. Additionally, it highlights the need to avoid applying the cream to unaffected skin areas to prevent irritation.*

FDA Label Image

Chemical Structure (Chemical Structure)

Tazarotene is a compound with the chemical formula of H3C and CH3. It is commonly used in dermatology for the treatment of acne and psoriasis. Tazarotene is a retinoid that works by promoting skin cell turnover and reducing inflammation. It is available in topical formulations for application to the skin.*

FDA Label Image

Label (Lbl721622420)

This text provides information about a medication in the form of a cream containing tazarotene as the active ingredient. It includes details on the concentration of tazarotene, list of inactive ingredients, storage instructions, and usage directions. The medication is specifically for topical use and warns against ophthalmic use. The text also mentions the manufacturer and provides a QR code for accessing additional patient information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.